Company profile: Microban
1.1 - Company Overview
Company description
- Provider of unique antimicrobial solution design, delivering built-in antimicrobial protection and odor control technologies for consumer, industrial, and medical products globally. Solutions for polymers, textiles, and coatings include Ascera, AEGIS Microbe Shield, LapisShield, SilverShield, and continuous Microban Antimicrobial Technologies.
Products and services
- Microban Antimicrobial Technologies: Industrial-grade systems engineered to be built into polymers, textiles, and coatings, delivering continuous suppression of microbial growth on consumer, industrial, and medical products and surfaces
- SilverShield: Silver-ion-based technology architected for polymers, coatings, textiles, and more, producing continuous protection against bacterial growth on treated components
- AEGIS® Microbe Shield: Quat-silane-based liquid antimicrobial formulated for urethane foams, coatings, and RIM processes, delivering long-term stability and durability in treated substrates
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Microban
Upfront Chromatography
HQ: Denmark
Website
- Description: Provider of customized protein separation processes and technologies for extraction and recovery of biotherapeutics, functional biomolecules, and macromolecular complexes. Denmark-based biotech with significant expertise and regulatory experience in developing and manufacturing customised industrial processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Upfront Chromatography company profile →
Ionpath
HQ: United States
Website
- Description: Provider of ion beam–based multiplexed tissue imaging and spatial proteomics solutions, including the MIBIscope system with instrumentation, validated reagents, and visualization software; MIBI technology imaging 40+ protein markers per scan; MIBIplus single-cell analysis detecting 50+ phenotypes; Spatial Proteomic Services for segmentation, classification, and spatial analysis; and conjugated antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ionpath company profile →
CytoSorbents
HQ: United States
Website
- Description: Provider of blood purification therapies and devices for treating life-threatening conditions, including CytoSorb to reduce excessive cytokines during ICU care and cardiac surgery; investigational DrugSorb-ATR to remove antithrombotic agents during cardiothoracic surgery; VetResQ for critically ill animals; ECOS-300CY for ex vivo organ perfusion; development-stage HemoDefend-RBC and HemoDefend-BGA for safer transfusions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CytoSorbents company profile →
Xcellerex
HQ: United States
Website
- Description: Provider of biomanufacturing technologies, developing and producing biomanufacturing systems and production-scale bioreactors that transform the speed and economics of producing therapeutic proteins, including biosimilars and vaccines. Offers OptiRun service solutions including maintenance, upgrades, calibration, remote support, plus equipment installation and qualification, scientific support, and training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xcellerex company profile →
Peak Proteins
HQ: United Kingdom
Website
- Description: Provider of chemistry services, established by ex-AstraZeneca protein biochemistry and structural biology scientists.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Peak Proteins company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Microban
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Microban
2.2 - Growth funds investing in similar companies to Microban
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Microban
4.2 - Public trading comparable groups for Microban
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →